FDA Determines Regulatory Review Period for EDWARDS INTUITY ELITE AORTIC VALVE Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the EDWARDS INTUITY ELITE AORTIC VALVE medical device, as a result of a patent extension application submitted to the US Patent and Trademark Office (USPTO)